InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 07/24/2019 12:50:22 PM

Wednesday, July 24, 2019 12:50:22 PM

Post# of 402948
News: $IPIX Innovation Pharma Makes Savvy Move in Partnering with Alfasigma for New IBD Drug

- GBI Research forecast the GI therapeutics market will reach $48.4 billion by 2022 - Major pharma, Alfasigma licensed IPIX's Brilacidin as a new drug for IBDs ulcerative proctitis and ulcerative proctosigmoiditis for $24 million in upfront and future milestone payments + 6% royaltie...

Got this from Innovation Pharma Makes Savvy Move in Partnering with Alfasigma for New IBD Drug
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News